Wojewodzki Szpital Specjalistyczny W Olsztynie — Clinical Trial Site

39 Registered trials

14 Currently recruiting

Organisation

Wojewodzki Szpital Specjalistyczny W Olsztynie

Location

Olsztyn, Poland

Identifier

ORG-100045911

Address

Ul. Zolnierska 18, 10-561, Poland

Departments

#3153: Klinika Nefrologii, Hipertensjologii i Chorób Wewnetrznych
5706:Oddzial Ginekologii Onkologicznej
Cardiology
Department of Cardiology and Intensive Cardiac Monitoring Unit
Klnika Endokrynologii, Diabetologii i Chorób Wewnętrznych (Endocrinology)
n/a
Oddzial Gastroenterologiczny
Oddzial Gastroenterologii
Oddzial Ginekologii Onkologicznej
Oddzial Kardiologii
Oddzial Kliniczny Nefrologiczny, Hipertensjologii i Chorob Wewnetrznych
Oddzial Kliniczny Onkologii I Hematologii
Oddział Gastroenterologiczny
Oddział Ginekologiczno-Położniczy
Oddział Kardiochirurgiczny
Oddział Kardiologiczny
Oddział Kliniczny Anestezjologii i Intensywnej Terapii
Oddział Kliniczny Nefrologiczny, Hipertensjologii i Chorób Wewnętrznych
Oddział Kliniczny Neurologiczny Oddział Udarowy
Oddział Neurologiczny
Oddział Neurologiczny Oddział Udarowy
Oddział Neurologiczny, Oddział Udarowy
Odział Kliniczny Nefreologiczny, Hipertensjologii i Chorob Wewnętrznych
Odział Kliniczny Nefrologiczny, Hipertensjologii i Chorób Wewnętrznych
PL10010: Oddzial Gastroenterologiczny
PL10010:Oddzial Gastroenterologii
PL10012: Oddzial Gastroenterologiczny
PL10021_Oddzial Gastroenterologiczny
Stacja Dializ

Clinical trials at this site (39)

Search interface

A Study of Zanubrutinib Versus Tacrolimus in Participants With Primary Membranous Nephropathy (ALMOND) Recruiting

2022-501147-32-00 Primary Membranous Nephropathy 10 2024-07-11
Treatment of infants under one year with acute lymphoblastic leukemia according to the Interfant-21 protocol Recruiting

2022-502503-30-00 Acute lymphoblastic leukemia 5 2022-12-15
A Phase 2, Multicenter, Study to Evaluate the Pharmacokinetics and Safety of Subcutaneous Ublituximab Administered at Various Injection Site… Recruiting

2025-523757-33-00 multiple sclerosis 4 2026-05-07
Optimal antiplatelet therapy in patients after coronary artery bypass grafting. Recruiting

2025-521892-30-00 Primary isolated CABG patients with stable coronary art 5 2025-11-24
Evaluating safety, efficacy and pharmacokinetics of a modified regimen of ublituximab (ENHANCE) Recruiting

2024-519284-18-00 Relapsing multiple sclerosis 5 2025-06-18
The effect of noradrenaline infusion versus standard blood pressure management on perioperative HYPotension in NOncaRdiac surgery. Recruiting

2023-508255-39-00 hypotension in non-cardiac surgery 5 2025-06-16
BOOSTER – Multicenter, Open Label, Randomized Control Phase III Trial Comparing the Efficacy and Safety of Two Rituximab Regimens in Mainten… Recruiting

2023-509755-13-00 Idiopathic steroid-sensitive nephrotic syndrome 5 2025-04-28
A Study to Test the Effectiveness and Safety of RO7790121 for induction and maintenance therapy in Patients with Moderately to Severely Acti… Recruiting

2024-513053-69-00 Moderately to Severely Active Crohn's Disease (CD) 5 2025-04-16
Clinical trial (study) comparing the efficacy and safety of valacyclovir used in the prevention and treatment of primary cytomegalovirus (CM… Recruiting

2023-508643-46-00 primary cytomegalovirus (CMV) infection 4 2024-08-02
A multicenter, randomized, double-blind, parallel group, placebo-controlled study to evaluate the efficacy and safety of iptacopan (LNP023) … Recruiting

2022-502160-20-00 Idiopathic Immune Complex Mediated Membranoproliferativ 5 2023-10-02
SACK Recruiting

2022-501600-10-00 Atrial fibrillation and Chronic Kidney Disease stage 5 5 2023-02-07
Empagliflozin and dapagliflozin for improvement of outcome in patients with acute heart failure Recruiting

2024-518685-27-00 acute/decompensated heart failure 5 2022-03-22
Selatogrel Outcome Study in Suspected Acute Myocardial Infarction Recruiting

2023-505438-85-00 Acute myocardial infarction (AMI) 5 2022-01-12
Roll Over Study for Patients Who Have Completed a Previous Oncology Study with Olaparib Recruiting

2024-512982-15-00 BRCA Mutated Ovarian Cancer Patients, Epithelian ovaria 5 2021-06-28
A study to determine if ravulizumab can help preserve kidney function in adults with immunoglobulin A nephropathy (IgAN) Ended

2023-507851-31-00 Immunoglobulin A Nephropathy (IgAN) 5 2024-09-23
A Phase 3 Placebo-controlled Study of Milvexian after an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack Ended

2022-501176-26-00 Acute Ischemic Stroke and High-Risk Transient Ischemic 5 2023-08-04
Efficacy and Safety of Combination Therapy with Guselkumab and Golimumab in Participants with Moderately to Severely Active Crohn's Disease Ended

2023-504741-32-00 Moderately to Severely Active Crohn's Disease 4 2022-11-30
Efficacy and Safety of Combination Therapy with Guselkumab and Golimumab in Participants with Moderately to Severely Active Ulcerative Colit… Ended

2023-504743-13-00 Moderately to Severely Active Ulcerative Colitis 4 2022-11-30
A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients with Multiple Sclerosis Ended

2023-505974-14-00 Multiple Sclerosis (MS) 5 2022-06-23
GRAVITI - A Phase 3 Study to Evaluate the Efficacy and Safety of Guselkumab Subcutaneous Induction Therapy in Participants with Moderately t… Ended

2023-504737-41-00 Moderately to Severely Active Crohn's Disease 5 2022-06-10
Ivabradine for PREVENTion of Myocardial Injury after Noncardiac Surgery (MINS) - PREVENT-MINS Trial Ended

2024-515226-81-00 Myocardial Injury after Noncardiac Surgery 5 2022-06-02
Phase 3 Study of Anifrolumab in Adult Patients with Active Proliferative Lupus Nephritis Ended

2023-506359-68-00 Active Proliferative Lupus Nephritis 5 2022-04-08
An Open Label Extension Study of Ublituximab in Subjects with Relapsing Multiple Sclerosis Ended

2024-516680-91-00 relapsing multiple sclerosis 5 2020-05-21
A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults with Primary Progressive Multiple Sclerosis Ended

2023-505980-36-00 Primary progressive multiple sclerosis (PPMS) 5 2019-09-19